Yujin Jung
M.S./PH.D. INTEGRATED COURSE from Mar 2022
Department of Biomedical Sciences, SNUCM
B.S. Department of Biomedical Biotechnology,
Dongguk University, Republic of Korea
Research interests
Tumor microenvironment, TNF, costimulatory receptor
Words
Health comes first.
E-mail: 202223856@snu.ac.kr
Patent
1. CD40 작용제 항체 및 이의 용도
(이창한, 정유진)
10-2024-0137368
2. 가용성 Fas 리간드 특이적 중화 항체 및 그 용도
(이창한, 정두현, 정유진, 정동진)
10-2025-0073416
Publications
6. Rapid CAR Screening and circRNA-driven CAR-NK Cells for Persistent Shed-resistant Immunotherapy
Signal Transduction and Targeted Therapy (IF: 52.7), 11, Article number: 129, 2026
(Co-corresponding) Joo-Yoon Chung†, Jisu Hong†, Su-Min Yee, Hye Won Lim, Dahye Lee, Sangwon Yoon,
Seung-Hwan Lee, Yujin Jung, Seung Hun Shin, Song Cheol Kim, Chang-Han Lee*, Mihue Jang*
# Co-first author, *Co-corresponding author
1. Dual Targeting of Tau Kinases and Autophagy by Abemaciclib Independent of CDK4/6 Inhibition
Advanced Science, 14 January 2026
(Jihui Han, June-Hyun Jeong, Dongjoon Lee, Yujin Jung, Yujin Jin, Sun Sun Jung, Haeng Jun Kim, Woo Youn
Kim, Chang-Han Lee, Inhee Mook-Jung)